Lifecore Biomedical Inc (LFCR)
6.58
-0.07
(-1.05%)
USD |
NASDAQ |
May 09, 16:00
6.58
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Revenue (TTM): 141.30M for May 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| May 31, 2023 | 135.28M |
| February 28, 2023 | 130.89M |
| November 30, 2022 | 140.69M |
| August 31, 2022 | 145.34M |
| May 31, 2022 | 143.61M |
| February 28, 2022 | 96.73M |
| November 30, 2021 | 104.02M |
| August 31, 2021 | 191.47M |
| May 31, 2021 | 285.48M |
| February 28, 2021 | 37.07M |
| November 30, 2020 | 145.31M |
| August 31, 2020 | 157.00M |
| May 31, 2020 | 160.07M |
| February 29, 2020 | 587.02M |
| November 30, 2019 | 589.64M |
| August 31, 2019 | 571.60M |
| May 31, 2019 | 557.56M |
| February 28, 2019 | 545.86M |
| November 30, 2018 | 535.21M |
| August 31, 2018 | 533.11M |
| May 31, 2018 | 524.23M |
| February 28, 2018 | 448.10M |
| November 30, 2017 | 439.76M |
| August 31, 2017 | 453.16M |
| May 31, 2017 | 469.78M |
| Date | Value |
|---|---|
| February 28, 2017 | 475.96M |
| November 30, 2016 | 469.38M |
| August 31, 2016 | 473.96M |
| May 31, 2016 | 476.92M |
| February 29, 2016 | 540.23M |
| November 30, 2015 | 548.77M |
| August 31, 2015 | 541.00M |
| May 31, 2015 | 539.26M |
| February 28, 2015 | 525.74M |
| November 30, 2014 | 513.59M |
| August 31, 2014 | 500.95M |
| May 31, 2014 | 476.81M |
| February 28, 2014 | 463.00M |
| November 30, 2013 | 454.48M |
| August 31, 2013 | 449.11M |
| May 31, 2013 | 441.71M |
| February 28, 2013 | 417.21M |
| November 30, 2012 | 379.41M |
| August 31, 2012 | 346.32M |
| May 31, 2012 | 317.55M |
| February 29, 2012 | 303.03M |
| November 30, 2011 | 296.48M |
| August 31, 2011 | 285.08M |
| May 31, 2011 | 276.73M |
| February 28, 2011 | 266.85M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
37.07M
Minimum
Feb 2021
589.64M
Maximum
Nov 2019
245.81M
Average
145.34M
Median
Aug 2022
Revenue (TTM) Benchmarks
| Aquestive Therapeutics Inc | 50.58M |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | 258.22M |
| Relmada Therapeutics Inc | -- |
| Jaguar Health Inc | 9.761M |